The current spurt in diagnostic tests on dengue and chikungunya in areas like New Delhi will help Dr Lal PathLabs post good Q2 volumes, says Om Manchanda, Chief Executive of the healthcare firm.
first published: Aug 30, 2016 11:59 am
A collection of the most-viewed Moneycontrol videos.

Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live

Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live

Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live

Redefining Distribution with Next-Gen Technology Solutions
You are already a Moneycontrol Pro user.

